Sionna Therapeutics (NASDAQ:SION) Trading Up 4.5% - Time to Buy?

Sionna Therapeutics, Inc. (NASDAQ:SION - Get Free Report) rose 4.5% during trading on Tuesday . The stock traded as high as $12.91 and last traded at $12.65. Approximately 11,004 shares were traded during mid-day trading, a decline of 95% from the average daily volume of 231,585 shares. The stock had previously closed at $12.10.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the company. Stifel Nicolaus started coverage on Sionna Therapeutics in a report on Tuesday, March 4th. They set a "buy" rating and a $32.00 price target on the stock. Guggenheim initiated coverage on Sionna Therapeutics in a research note on Tuesday, March 4th. They issued a "buy" rating and a $45.00 price target for the company. Finally, TD Cowen assumed coverage on shares of Sionna Therapeutics in a research note on Tuesday, March 4th. They set a "buy" rating on the stock.

Sionna Therapeutics Stock Performance

Sionna Therapeutics (NASDAQ:SION - Get Free Report) last released its earnings results on Thursday, March 20th. The company reported ($3.38) EPS for the quarter, missing the consensus estimate of ($2.68) by ($0.70).

Sionna Therapeutics Company Profile

We are a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (“CF”) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (“CFTR”) protein to deliver clinically meaningful benefit to CF patients.